Organon (OGN) P/B (2021 - 2026)
Organon (OGN) P/B from May 14, 2021 to Jun 2, 2026. The TTM Organon (OGN) P/B is 3.89. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/B
Annual P/B change of Organon (OGN)
| Year | P/B | Change |
|---|---|---|
| 2026 | 3.89 | +56.80% |
| 2025 | 2.48 | -69.54% |
| 2024 | 8.15 | -230.22% |
| 2023 | -6.26 | -6.10% |
| 2022 | -6.66 | +30.13% |
| 2021 | -5.12 | N/A |
Comparison Organon (OGN) P/B with competitors
Organon (OGN) P/B is 3.89.
| Ticker | Name | P/B | Upside |
|---|---|---|---|
| AMRN | Amarin Corp | 0.67 | -82.86% |
| GRFS | Grifols SA | 0.86 | -77.85% |
| SNY | Sanofi | 1.25 | -67.83% |
| BIIB | Biogen Inc | 1.55 | -60.07% |
| PFE | Pfizer Inc | 1.66 | -57.40% |
| GSK | GSK Plc | 4.30 | +10.39% |
| MIRA | Mira Pharmaceuticals Inc | 4.90 | +25.88% |
| BMY | Bristol-Myers Squibb Company | 5.91 | +51.86% |
| AZN | Astrazeneca plc | 6.07 | +55.97% |
| NVO | Novo Nordisk | 6.24 | +60.34% |
| MRK | Merck & Co Inc | 6.47 | +66.25% |
| JNJ | Johnson & Johnson | 6.86 | +76.27% |
| GILD | Gilead Sciences Inc | 7.06 | +81.41% |
| NVS | Novartis AG | 7.49 | +92.46% |
| MDCX | MDCorp | 13.18 | +238.67% |
| NSRX | Nasus Pharma Ltd | 14.22 | +265.39% |
| AMGN | AMGEN Inc | 19.74 | +407.23% |
| SCLX | Scilex Holding Company | 28.85 | +641.31% |
| LLY | Lilly(Eli) & Company | 30.95 | +695.27% |
| ABBV | Abbvie Inc | 50.46 | +1196.59% |